DAFNA Capital Management LLC
Q3 2025 13F Holdings
- Locationlos angeles, CA
- Num holdings
75
- Value ($000)
$404,786
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001389933
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
RJR1 STEREOTAXIS INC | COM NEW | 85916J409 | $42.55 M | 11 % | 13,680,554 | ||
KRE SPDR S&P BIOTECH ETF | ETF | 78464A870 | $40.23 M | 10 % | 401,505 | ||
RVMD REVOLUTION MEDICINES INC | COM | 76155X100 | $30.69 M | 8 % | 657,176 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $21.71 M | 5 % | 394,940 | ||
ATRC ATRICURE INC | COM | 04963C209 | $20.88 M | 5 % | 592,273 | ||
MERUS BV | COM | N5749R100 | $20.76 M | 5 % | 220,451 | ||
IBB ISHARES NASDAQ BIOTECH INDX | ETF | 464287556 | $14.80 M | 4 % | 102,500 | ||
IDYA IDEAYA BIOSCIENCES INC | COM | 45166A102 | $14.69 M | 4 % | 539,923 | ||
AXGN AXOGEN INC | COM | 05463X106 | $13.24 M | 3 % | 742,282 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | $11.56 M | 3 % | 287,939 |
Rows Per Page
10
- 10
- 50
- 100